Renaissance Technologies LLC Boosts Position in P3 Health Partners Inc. (NASDAQ:PIII)

Renaissance Technologies LLC raised its stake in shares of P3 Health Partners Inc. (NASDAQ:PIII) by 188.1% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 111,800 shares of the company’s stock after buying an additional 73,000 shares during the quarter. Renaissance Technologies LLC’s holdings in P3 Health Partners were worth $50,000 at the end of the most recent reporting period.

A number of other hedge funds have also added to or reduced their stakes in PIII. GSA Capital Partners LLP grew its holdings in P3 Health Partners by 110.6% during the 1st quarter. GSA Capital Partners LLP now owns 565,522 shares of the company’s stock valued at $582,000 after buying an additional 296,936 shares in the last quarter. Sanders Morris Harris LLC grew its holdings in P3 Health Partners by 16.3% during the 2nd quarter. Sanders Morris Harris LLC now owns 142,998 shares of the company’s stock valued at $64,000 after buying an additional 20,000 shares in the last quarter. Finally, Emfo LLC grew its holdings in shares of P3 Health Partners by 39.8% during the second quarter. Emfo LLC now owns 1,427,689 shares of the company’s stock worth $643,000 after purchasing an additional 406,418 shares in the last quarter. Hedge funds and other institutional investors own 7.75% of the company’s stock.

P3 Health Partners Stock Up 2.0 %

Shares of NASDAQ PIII opened at $0.32 on Tuesday. P3 Health Partners Inc. has a 12 month low of $0.30 and a 12 month high of $1.78. The company has a current ratio of 0.69, a quick ratio of 0.69 and a debt-to-equity ratio of 0.80. The firm has a market capitalization of $99.92 million, a price-to-earnings ratio of -0.54 and a beta of 1.14. The business has a 50-day moving average of $0.47 and a 200-day moving average of $0.55.

P3 Health Partners (NASDAQ:PIII) last issued its quarterly earnings data on Wednesday, August 7th. The company reported ($0.15) EPS for the quarter, missing the consensus estimate of ($0.08) by ($0.07). P3 Health Partners had a negative return on equity of 43.19% and a negative net margin of 4.95%. The business had revenue of $379.16 million for the quarter, compared to analysts’ expectations of $364.50 million. Sell-side analysts expect that P3 Health Partners Inc. will post -0.23 earnings per share for the current fiscal year.

Insider Transactions at P3 Health Partners

In other P3 Health Partners news, major shareholder Pacific Founders Ugp I. Chicago acquired 80,000 shares of the business’s stock in a transaction dated Friday, September 6th. The stock was bought at an average price of $0.49 per share, with a total value of $39,200.00. Following the completion of the acquisition, the insider now owns 76,785,438 shares of the company’s stock, valued at $37,624,864.62. This trade represents a 0.00 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink. Over the last 90 days, insiders acquired 400,000 shares of company stock valued at $205,600. 17.86% of the stock is owned by corporate insiders.

About P3 Health Partners

P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc was founded in 2020 and is based in Henderson, Nevada.